Global Head of Clinical Development - Solid Tumor (BOSTON)
Company: Takeda Pharmaceutical
Location: Boston
Posted on: March 25, 2026
|
|
|
Job Description:
By clicking the “Apply” button, I understand that my employment
application process with Takeda will commence and that the
information I provide in my application will be processed in line
with Takeda’s Privacy Notice and Terms of Use. I further attest
that all information I submit in my employment application is true
to the best of my knowledge. Job Description Are you looking for a
patient-focused, innovation-driven company that will inspire you
and empower you to shine? Join us as a Vice President , Global
Clinical Lead - Solid Tumor in our Cambridge office. At Takeda, we
are transforming the pharmaceutical industry through our
R&D-driven market leadership and being a values-led company. To
do this, we empower our people to realize their potential through
life-changing work. Certified as a Global Top Employer, we offer
stimulating careers, encourage innovation, and strive for
excellence in everything we do. We foster an inclusive,
collaborative workplace, in which our global teams are united by an
unwavering commitment to deliver Better Health and a Brighter
Future to people around the world. Here, you will be a vital
contributor to our inspiring, bold mission. OBJECTIVES: Responsible
for leading as the Global Clinical Lead a large solid tumor
oncology franchise that encompass multiple late stage and early
phase programs . Ensures ongoing review and agreement of the
Therapy Area Strategy and associated documents formulated by the
OTAU leader prior to their review and approval by appropriate
governance committees. Oversees the development and execution of
the Integrated Disease Area Strategy (IDAS) and overall Integrated
Global Development Plan (IGDP). Responsible for review of synopses,
other relevant clinical study documents and critical Study Results.
Provide leadership and oversight of specific OTAU related programs
and if applicable other indication specific clinical leads.
Responsible for providing guidance to TA leaders on regional
specificities within Therapeutic Area. ACCOUNTABILITIES: - Clinical
Development team participation and leadership - Accountable to
Oncology Clinical Science Head to provide strategic clinical input
on assigned clinical studies. - Consistent with the Takeda R&D
Oncology Therapeutic Area Unit strategy, goals and objectives, this
leader will partner with the other key functions and leaders and
members of Oncology Precision and Translational Medicine, Oncology
Portfolio Strategy Group, Global Regulatory Affairs, Quantitative
and Clinical Pharmacology, other R&D Functional Line Oncology
Therapeutic Area Leads, Global Product Launch Strategy Oncology
Franchise Leads, Regional Oncology Franchise Leads, Oncology Drug
Development Unit (DDU) and other Oncology extended leadership, to
drive the alignment on global clinical research and development
strategy as related to internal and external pipeline and
non-pipeline initiatives for the Takeda R&D Oncology Community
across all regions - Part of the Oncology Clinical Sciences
Leadership Team providing key input in strategic planning and
connectivity for the overall Oncology Clinical Sciences group -
Leads the Global Development Team (US, EU, and others) managing
both the US/EU Development Team and the Japan/ China Development
team for assigned compounds. In some cases may lead the US/EU
Development Team but more likely will oversee the study physician
and/or clinical scientist leads responsible for leading the team.
Emphasis will be on insuring that the development teams are
proactively identifying contingencies, potential risks and
strategies to address future obstacles. - Directs Development Team
strategy and deliverables overseeing the Development Strategy,
Clinical Development Plan and Clinical Protocols. Recommends scope,
complexity and size, which influence the budget of all aspects of a
program. Provides continual critical evaluation of the development
strategy to maintain a state-of-the-art development plan that is
competitive and consistent with the latest regulatory requirements,
proactive identification of challenges, and development of
contingency plans to meet them. - Responsible for high impact
global decisions: interpreting data from ongoing internal and
external studies, assessing the medical and scientific implications
and making recommendations that impact regional and global
development such as “go/no go” decisions or modification of
development plans or study designs that may have a significant
impact on timelines or product labeling. Plans clinical development
strategies in context of medical/clinical significance considering
how a given product will fit in with current treatments, standard
of care, and unmet medical need. - Accountable for ensuring
regional strategies and trade-offs in regional requirements are
well articulated in the global strategy documentation and that
stakeholders are appropriately briefed. - Providing strategic input
into global development strategies and plans for all compounds in
OTAU. - Providing clinical and strategic support to evaluation of
external compounds (alliances and in-licensing opportunities) -
Primary interface with Medical Affairs team for strategy and to
support of product commercial efforts - Contributing to the
creation and maintenance of regional KOL network - Providing
recommendations for GDT leader nominations and reviewers of
external compounds as part of business development efforts -
Liaison with Clinical Operations and Project Management for
co-ordination of logistics study planning and implementation -
Synopsis / Protocol Development, Study Execution, & Study
Interpretation - Consistent with membership of the Clinical Review
Board Committee, responsible for critical review of synopses,
protocols, IBs and relevant clinical documents relating to studies
in assigned compounds. - Trial Medical Monitoring - Reviews and
assesses overall safety information in conjunction with
Pharmacovigilance and Medical Monitor of record for assigned
compounds. - External Interactions - Oversees and leads all
clinical science activities involved in interactions with FDA,
other regulatory agencies and key opinion leaders relevant to
assigned compounds. - Responsible for evaluation of external
interactions in the context of overall development strategies using
complex problem solving in the region but in context of a global
environment. - Proactive identification of challenges and
development of contingency plans as appropriate. - Due Diligence,
Business Development and Alliance Projects - Responsible for
evaluation of potential business development opportunities in the
region but with the context of a global environment. - Conducts due
diligence evaluations, of clinical development plans for potential
alliances and or in-licensing opportunities. - Serves as clinical
contact point for ongoing alliance projects and interface with
partner to achieve Takeda’s strategic goals while striving to
maintain good working relationship between Takeda and partner. -
Assigns and manages clinical science staff who are involved in many
of these activities. - Leadership, Task Force Participation, Upper
Management Accountability - Interacts directly with research
division based on pertinent clinical and development expertise and
in all aspects relating to assigned compound in regional area.
Leads TGRD internal teams and global cross-functional teams. Works
with functional leadership to prioritize projects within the
therapeutic area. - Hires, manages, mentors, motivates, empowers,
develops and retains staff to support assigned activities. Conducts
performance reviews and drive goal setting and development
planning. EDUCATION, EXPERIENCE, KNOWLEDGE AND SKILLS: Experience -
MD or combined MD/PhD or internationally recognized equivalent with
minimum 15 years pharmaceutical research experience, including
minimum 10 years late phase clinical development experience with a
focus on medical oncology - Clinical Training and Clinical
Experience in Hematology/Oncology and/or Medical Oncology
especially in solid tumor malignancies - Strong depth of scientific
and clinical understanding and experience in cancer biology
especially in immune based therapies. - Experience in conducting
and/ or leading multiple clinical trials involving immune based
therapies - Proven experience in successfully leading and
supervising direct reports including several physicians, physician
scientists, scientists within a clinical development team in a
global matrix environment. - Demonstrated ability to foster a
high-performance culture and build organizational capabilities. -
Strong leadership commitment to diversity, equity and inclusion,
with experience in creating an inclusive and collaborative team
environment that leverages diverse perspectives. - Previous
experience in successfully leading several clinical development
team/matrix team with responsibility for Global studies in multiple
regions. Clinical Development experience beyond US/EU - Solid and
Multiple
Keywords: Takeda Pharmaceutical, Manchester , Global Head of Clinical Development - Solid Tumor (BOSTON), Science, Research & Development , Boston, New Hampshire